Erector Spinae Plane (ESP) Block for Renal Colic

Sponsor
Stony Brook University (Other)
Overall Status
Recruiting
CT.gov ID
NCT05323175
Collaborator
(none)
24
1
2
14.2
1.7

Study Details

Study Description

Brief Summary

Comparing standard of care to erector spinae plane block for acute renal colic pain.

Condition or Disease Intervention/Treatment Phase
  • Drug: Ropivacaine injection
  • Other: Standard of care medications
Phase 4

Detailed Description

Will compare at times 0, 10 minute, 20 minute, 40 minute and 60 minutes after local nerve block given.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
24 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Standard of care group + sham normal saline ESP block vs Standard of care + Ropivacaine ESP nerve Block groupStandard of care group + sham normal saline ESP block vs Standard of care + Ropivacaine ESP nerve Block group
Masking:
Single (Participant)
Masking Description:
Participant will not know which type of block they receive
Primary Purpose:
Other
Official Title:
Can Erector Spinae Plane (ESP) Block Better Relieve Acute Renal Colic Pain Than Standard of Care
Actual Study Start Date :
Apr 25, 2022
Anticipated Primary Completion Date :
Jul 1, 2023
Anticipated Study Completion Date :
Jul 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: ESP Nerve Block for Renal colic

On top of receiving standard of care, At T8 nerve level, with ultrasound guidance to bathe the nerve

Drug: Ropivacaine injection
Local anesthesia injected under ultrasound guidance

Active Comparator: Standard of care

Whatever medications the clinician normally treats renal colic with

Other: Standard of care medications
Whatever the ED clinicians normally give for renal colic pain

Outcome Measures

Primary Outcome Measures

  1. Baseline Pain before intervention [Before the ESP Block]

    Using the Visual Analog Scale for Pain Assessment Tool with 0 meaning "No pain" and 10 meaning "Unbearable Pain"

  2. Pain score at 10 minutes [10 minutes after the ESP Block]

    Using the Visual Analog Scale for Pain Assessment Tool with 0 meaning "No pain" and 10 meaning "Unbearable Pain"

  3. Pain score at 20 minutes [20 minutes after ESP Block]

    Using the Visual Analog Scale for Pain Assessment Tool with 0 meaning "No pain" and 10 meaning "Unbearable Pain"

  4. Pain score at 40 minutes [40 minutes after ESP Block]

    Using the Visual Analog Scale for Pain Assessment Tool with 0 meaning "No pain" and 10 meaning "Unbearable Pain

  5. Pain score at 60 minutes [60 minutes after ESP Block]

    Using the Visual Analog Scale for Pain Assessment Tool with 0 meaning "No pain" and 10 meaning "Unbearable Pain

Secondary Outcome Measures

  1. Need for extra opiates [Starting from time 0 after the ESP Block intervention completed till discharge or urology intervention]

    Record how much opioids patients receives starting after the ESP Block for both the "standard of care" patients and the ESP Block group

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • 18 to 65 years old

  • ASA Level I and II

  • flank pain concerning for renal colic in ED

Exclusion Criteria:
  • pregnant women

  • subjects unable to appreciate ESP block landmarks under ultrasound

  • skin infection over needle site insertion

  • Allergy to local anesthesia (lidocaine/Ropivacaine)

  • bleeding disorders

  • serious cardiac, lung, liver or kidney dysfunction

  • history of spine surgery

  • history of spinal infection

  • history of epidural injection within 6 months

  • acute exacerbation of serious mental disease

  • unable to consent

  • unable to communicate pain level

Contacts and Locations

Locations

Site City State Country Postal Code
1 StonyBrook University Hospital Stony Brook New York United States 11794

Sponsors and Collaborators

  • Stony Brook University

Investigators

  • Principal Investigator: Michael Secko, MD, StonyBrook University Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Gilbert Tetteh, Medical Doctor, Emergency Department Attending, Stony Brook University
ClinicalTrials.gov Identifier:
NCT05323175
Other Study ID Numbers:
  • IRB2021-00518
First Posted:
Apr 12, 2022
Last Update Posted:
Jun 3, 2022
Last Verified:
May 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
Yes
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Gilbert Tetteh, Medical Doctor, Emergency Department Attending, Stony Brook University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 3, 2022